Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:813650.
doi: 10.1155/2012/813650. Epub 2012 Dec 11.

Laparoscopic sleeve gastrectomy for mildly obese patients (Body Mass Index of 30 <35 kg/m²): operative outcome and short-term results

Roger Noun  1 , Ghassan Chakhtoura, Marwan Nasr, Judith Skaff, Naîm Choucair, Nathalie Rkaybi, Carla Tohme-Noun
Affiliations

Laparoscopic sleeve gastrectomy for mildly obese patients (Body Mass Index of 30 <35 kg/m²): operative outcome and short-term results

Roger Noun et al. J Obes. 2012.

Abstract

Background: Data concerning laparoscopic sleeve gastrectomy (LSG) in mild obesity are under investigation.

Aim/objective: May 2010 to May 2012, 122 consecutive patients with preoperative body mass index (BMI) of 33 ± 2.5 kg/m² (range 30-34.9) undergoing LSG were studied. Mean age was 33 ± 10 years (range 15-60), and 105 (86%) were women. Mean preoperative weight was 91 ± 9.7 kg (range 66-121), and preoperative excess weight was 30 ± 6.7 kg (range 19-43). Comorbidities were detected in 44 (36%) patients.

Results: Mean operative time was 58 ± 15 min (range 40-95), and postoperative stay was 1.8 ± 0.19 days (range 1.5-3). There were no admissions to intensive care unit and no deaths within 30 days of surgery. The rates of leaks and strictures were 0%, and of hemorrhage 1.6%. At 12 months, BMI decreased to 24.7 ± 2, and the percentage of excess weight loss (% EWL) reached 76.5%. None of the patients had a BMI below 20 kg/m². Comorbidities resolved in 70.5% or improved in 29.5%. Patient satisfaction scoring (1-5) at least 1 year after was 4.6 ± 0.8 for body image and 4.4 ± 0.6 for food tolerance.

Conclusion: LSG for mildly obese patients has proved to be technically relatively easy, safe, and benefic in the short term.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Oral and intravenous contrast abdominal multidetector CT scan showing infarction of the upper-medial part of the spleen and the adjacent gastric sleeve.
See this image and copyright information in PMC

References

    1. Felberbauer FX, Langer F, Shakeri-Manesch S, et al. Laparoscopic sleeve gastrectomy as an isolated bariatric procedure: intermediate-term results from a large series in three Austrian centers. Obesity Surgery. 2008;18(7):814–818. - PubMed
    1. D'Hondt M, Vanneste S, Pottel H, et al. Laparoscopic sleeve gatrectomy as a single procedure for the treatment of morbid obesity and the resulting quality of life, resolution of comorbidities, food tolerance, and 6-year weight loss. Surgical Endoscopy. 2011;25:2498–2504. - PubMed
    1. Chouillard EK, Karaa A, Elkhoury M, Greco VJ. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity: case-control study. Surgery for Obesity and Related Diseases. 2011;7(4):500–505. - PubMed
    1. Boza C, Salinas J, Salgado N, et al. Laparoscopic sleeve gastrectomy as a stand-alone procedure for morbid obesity: report of 1,000 cases and 3-year follow-up. Obesity Surgery. 2012;22:866–871. - PubMed
    1. Gluck B, Movitz B, Jansma S, et al. Laparoscopic sleeve gastrectomy is a safe and effective bariatric procedure for the lower BMI, (35–43 kg/m2) population. Obesity Surgery. 2011;21:1168–1171. - PMC - PubMed